Drugs & TargetsFree Amgen enters into agreement with GSK to reclaim rights to Prolia, XGEVA, and Vectibix December 18, 2015Vol.41 No.46
Drugs & TargetsFree Stem Cell Theranostics and CapellaBio launch collaboration on cardiotoxicity December 18, 2015Vol.41 No.46
Conversation with The Cancer LetterFree Pilot: Don’t Change 510(k), Put More Money Into Enforcing FDA Reporting Laws December 18, 2015Vol.41 No.46By Matthew Bin Han Ong
FreeIn Brief Society of Toxicology honors award recipients, including Richard Adamson with the Founders Award December 18, 2015Vol.41 No.46
FreeIn Brief Joseph Smith Jr. awarded Huggins Medal from the Society of Urologic Oncology December 18, 2015Vol.41 No.46
Conversation with The Cancer LetterFree Vodra: 510(k) Does Not Assess Risk; Needs to be Split Into Multiple Risk Groups December 18, 2015Vol.41 No.46
FreeIn Brief Bhramar Mukherjee appointed associate director for population science at University of Michigan Comprehensive Cancer Center December 18, 2015Vol.41 No.46
FreeIn Brief John “Drew” Ridge elected medical staff president at Fox Chase – Temple Health December 18, 2015Vol.41 No.46
Free The Root Causes of Harm From Medical Devices December 18, 2015Vol.41 No.46By Matthew Bin Han Ong
